Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_provenance.
- befree-20150227 importedOn "2015-02-27" NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_provenance.
- NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_assertion wasGeneratedBy ECO_0000203 NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_provenance.
- NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_assertion wasDerivedFrom befree-20150227 NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_provenance.
- NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_assertion SIO_000772 15548710 NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_provenance.
- NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_assertion evidence source_evidence_literature NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_provenance.
- NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_assertion description "[Thus, inhibition of PI3K activity with concomitant administration of chemotoxic compounds may prove beneficial in preventing the development of drug resistance in patients with hormone-refractory prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625581.RAvri6HxydSO2N5wMgIOVPc--LDDT16pEnjqY3Gb89jac130_provenance.